Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0034250,
umls-concept:C0060659,
umls-concept:C0072677,
umls-concept:C0205460,
umls-concept:C0220781,
umls-concept:C0220825,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1260969,
umls-concept:C1521802,
umls-concept:C1521827,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1709634,
umls-concept:C1883254
|
pubmed:issue |
7
|
pubmed:dateCreated |
1989-8-4
|
pubmed:abstractText |
All three amino-substituted 3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-b]pyridazines (5, 19, and 20) structurally related to formycin A were prepared and tested for their antitumor and antiviral activity in cell culture. Dehydrative coupling of 4-amino-5-chloro-3-hydrazinopyridazine (7) with 3,4,6-tri-O-benzoyl-2,5-anhydro-D-allonic acid (6) in the presence of DCC and subsequent thermal ring closure of the reaction product (8) provided 8-amino-7-chloro-3-(2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)- triazolo[4,3-b]pyridazine (9). Dehalogenation of 9, followed by debenzoylation, gave the formycin congener 8-amino-3-beta-D-ribofuranosyl-1,2,4- triazolo[4,3-b]pyridazine (5). Similar condensation of 5-amino-4-chloro-3-hydrazinopyridazine (13) with 6 and dehalogenation of the cyclized product (16), followed by debenzoylation, gave the isomeric 7-amino-3-beta-D-ribofuranosyl-1,2,4- triazolo[4,3-b]pyridazine (19). DCC-mediated coupling of 6 with 6-chloro-3-hydrazinopyridazine (12), followed by ammonolysis of the cyclized product (21) with liquid NH3, provided a convenient route to 6-amino-3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-b]pyridazine (20). The structural assignment of 5 was made by single-crystal X-ray diffraction analysis. Compounds 5, 19, 20, and certain deprotected nucleoside intermediates were evaluated against L1210, WI-L2, and CCRF-CEM tumor cell lines, as well as against DNA and RNA viruses in culture. These compounds did not exhibit any significant antitumor or antiviral activity in vitro.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Formycins,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridazines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1547-51
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2738890-Animals,
pubmed-meshheading:2738890-Antibiotics, Antineoplastic,
pubmed-meshheading:2738890-Antineoplastic Agents,
pubmed-meshheading:2738890-Antiviral Agents,
pubmed-meshheading:2738890-Chemical Phenomena,
pubmed-meshheading:2738890-Chemistry,
pubmed-meshheading:2738890-DNA Viruses,
pubmed-meshheading:2738890-Formycins,
pubmed-meshheading:2738890-Humans,
pubmed-meshheading:2738890-Leukemia, Lymphoid,
pubmed-meshheading:2738890-Leukemia L1210,
pubmed-meshheading:2738890-Mice,
pubmed-meshheading:2738890-Molecular Conformation,
pubmed-meshheading:2738890-Pyridazines,
pubmed-meshheading:2738890-RNA Viruses,
pubmed-meshheading:2738890-Tumor Cells, Cultured
|
pubmed:year |
1989
|
pubmed:articleTitle |
Synthesis and biological evaluation of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-b)pyridazines related to formycin prepared via ring closure of pyridazine precursors.
|
pubmed:affiliation |
ICN Nucleic Acid Research Institute, Costa Mesa, California 92626.
|
pubmed:publicationType |
Journal Article
|